Daniel Lucius Vasella MD (born 1953) is Chairman and Chief Executive Officer (CEO) of the Swiss pharmaceutical company Novartis AG. Switzerland (English pronunciation; Schweiz Swiss German: Schwyz or Schwiiz Suisse Svizzera Svizra officially the Swiss Confederation Novartis International AG is a multinational Pharmaceutical company based in Basel Switzerland that manufactures drugs such as Clozapine He is married and has three children.
The Time Magazine included Vasella in its list of 100 most influential people of 2004. Time (trademarked in capitals as TIME) is a weekly American Newsmagazine, similar to Newsweek and The Time 100 is an annual list of the 100 most influential people in the world as assembled by Time.
He completed the Program for Management Development (PMD) at Harvard Business School in 1989. Harvard Business School ( HBS) is a renowned Business school in the United States
He is the author of a book, co-written with Robert Slater titled "Magic Cancer Bullet" where he tells the story of how Gleevec came to be - which is a successful cancer drug representing the fruits of rational drug-design. Imatinib is a drug used to treat certain types of Cancer. It is currently marketed by Novartis as Gleevec ( USA) or Glivec
Articles: